226 related articles for article (PubMed ID: 24123095)
1. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
2. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Vita R; Saraceno G; Trimarchi F; Benvenga S
Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
[TBL] [Abstract][Full Text] [Related]
3. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
4. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
5. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
[TBL] [Abstract][Full Text] [Related]
6. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
7. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.
Morelli S; Reboldi G; Moretti S; Menicali E; Avenia N; Puxeddu E
Endocrine; 2016 Jun; 52(3):571-8. PubMed ID: 26537478
[TBL] [Abstract][Full Text] [Related]
8. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
9. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
[TBL] [Abstract][Full Text] [Related]
10. Serum thyrotropin levels following levothyroxine administration at breakfast.
Perez CL; Araki FS; Graf H; de Carvalho GA
Thyroid; 2013 Jul; 23(7):779-84. PubMed ID: 23363386
[TBL] [Abstract][Full Text] [Related]
11. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
12. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
13. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
Shimon I; Cohen O; Lubetsky A; Olchovsky D
Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
16. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients].
Grussendorf M; Vaupel R; Wegscheider K
Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873
[TBL] [Abstract][Full Text] [Related]
17. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
18. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
19. Timing of levothyroxine administration affects serum thyrotropin concentration.
Bach-Huynh TG; Nayak B; Loh J; Soldin S; Jonklaas J
J Clin Endocrinol Metab; 2009 Oct; 94(10):3905-12. PubMed ID: 19584184
[TBL] [Abstract][Full Text] [Related]
20. Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?
Hoermann R; Midgley JE; Larisch R; Dietrich JW
Eur J Endocrinol; 2013 Feb; 168(2):271-80. PubMed ID: 23184912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]